slotkoers
Warsaw S.E.
00:00:00 31-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
18
PLN
|
+0,56%
|
|
-11,76%
|
-.--%
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Marktkapitalisatie
1 |
31,05
|
20,39
|
17,19
|
20,88
|
21,12
|
31,2
|
Bedrijfswaarde
1 |
50,74
|
41,81
|
38,06
|
35,42
|
34,86
|
50,72
|
K/w-verhouding
|
31
x
|
17,9
x
|
13,5
x
|
16,8
x
|
10,8
x
|
9,23
x
|
Dividendrendement
|
-
|
-
|
-
|
2,35%
|
-
|
3,15%
|
Marktkapitalisatie/omzet
|
0,92
x
|
0,51
x
|
0,37
x
|
0,43
x
|
0,32
x
|
0,39
x
|
Bedrijfswaarde/omzet
|
1,51
x
|
1,04
x
|
0,82
x
|
0,73
x
|
0,53
x
|
0,64
x
|
Bedrijfswaarde/EBITDA
|
7,47
x
|
5,83
x
|
5,01
x
|
5,24
x
|
4,72
x
|
4,5
x
|
Bedrijfswaarde/FCF
|
42,9
x
|
-54,4
x
|
214
x
|
2,38
x
|
4,46
x
|
-16,6
x
|
FCF Yield
|
2,33%
|
-1,84%
|
0,47%
|
41,9%
|
22,4%
|
-6,04%
|
Price to Book
|
0,6
x
|
0,39
x
|
0,32
x
|
0,38
x
|
0,71
x
|
0,96
x
|
Aantal aandelen (in duizenden)
|
2.456
|
2.456
|
2.456
|
2.456
|
2.456
|
2.456
|
Referentieprijs
2 |
12,64
|
8,300
|
7,000
|
8,500
|
8,600
|
12,70
|
Datum van publicatie
|
17/05/18
|
14/05/19
|
14/05/20
|
13/05/21
|
30/05/22
|
30/05/23
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Omzet
1 |
33,57
|
40,24
|
46,63
|
48,33
|
65,32
|
79,62
|
EBITDA
1 |
6,797
|
7,171
|
7,604
|
6,761
|
7,388
|
11,28
|
Bedrijfsresultaat (EBIT)
1 |
2,926
|
3,393
|
3,348
|
2,359
|
4,589
|
8,376
|
Operationele Marge
|
8,72%
|
8,43%
|
7,18%
|
4,88%
|
7,03%
|
10,52%
|
Resultaat voor belastingen (EBT)
1 |
1,729
|
1,986
|
1,927
|
2,176
|
4,329
|
6,39
|
Nettowinst (verlies)
1 |
1,001
|
1,137
|
1,272
|
1,242
|
1,961
|
3,381
|
Nettomarge
|
2,98%
|
2,83%
|
2,73%
|
2,57%
|
3%
|
4,25%
|
WPA
2 |
0,4076
|
0,4629
|
0,5177
|
0,5054
|
0,7982
|
1,377
|
Free Cash Flow
1 |
1,184
|
-0,7691
|
0,1781
|
14,86
|
7,82
|
-3,065
|
FCF-marge
|
3,53%
|
-1,91%
|
0,38%
|
30,74%
|
11,97%
|
-3,85%
|
Kasstroomconversie (ebitda)
|
17,42%
|
-
|
2,34%
|
219,74%
|
105,84%
|
-
|
Kasstroomconversie (nettowinst)
|
118,23%
|
-
|
14,01%
|
1.196,6%
|
398,84%
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
0,2000
|
-
|
0,4000
|
Datum van publicatie
|
17/05/18
|
14/05/19
|
14/05/20
|
13/05/21
|
30/05/22
|
30/05/23
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Nettoschuldpositie
1 |
19,7
|
21,4
|
20,9
|
14,5
|
13,7
|
19,5
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
2,898
x
|
2,987
x
|
2,744
x
|
2,151
x
|
1,859
x
|
1,73
x
|
Free Cash Flow
1 |
1,18
|
-0,77
|
0,18
|
14,9
|
7,82
|
-3,06
|
ROE (netto-inkomsten/eigen vermogen)
|
1,96%
|
2,18%
|
2,38%
|
2,28%
|
4,63%
|
10,8%
|
ROA (netto-inkomsten/totale activa)
|
2,34%
|
2,62%
|
2,5%
|
1,75%
|
3,97%
|
7,91%
|
Totale activa
1 |
42,73
|
43,41
|
50,83
|
70,77
|
49,36
|
42,73
|
Nettoactief per aandeel
2 |
21,00
|
21,50
|
22,00
|
22,30
|
12,20
|
13,30
|
Cashflow per aandeel
2 |
0,4200
|
0,4300
|
0,4900
|
1,040
|
2,020
|
1,410
|
Capex
1 |
4,18
|
4,47
|
3,67
|
1,83
|
1,57
|
9,36
|
Capex/omzet
|
12,44%
|
11,1%
|
7,87%
|
3,79%
|
2,4%
|
11,76%
|
Datum van publicatie
|
17/05/18
|
14/05/19
|
14/05/20
|
13/05/21
|
30/05/22
|
30/05/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -.--% | 11,22 mln. | | +15,91% | 41,97 mld. | | +22,40% | 22,34 mld. | | +18,48% | 15,25 mld. | | +16,12% | 14 mld. | | +45,12% | 12,06 mld. | | -9,58% | 6,8 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +14,18% | 5,49 mld. |
Generieke geneesmiddelen
|